tiprankstipranks
Hexima Ltd (AU:HXL)
ASX:HXL
Australian Market

Hexima Ltd (HXL) Share Price & Analysis

0 Followers

HXL Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.01 - AU$0.02
Previous CloseAU$0.01
Volume2.50K
Average Volume (3M)332.20K
Market Cap
AU$1.84M
Enterprise Value-AU$2.12M
Total Cash (Recent Filing)AU$3.96M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-2.4
Beta0.34
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume332,199
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

4.96%0.00%0.00%95.04%
4.96%
Insiders
0.00% Other Institutional Investors
95.04% Public Companies and
Individual Investors

HXL FAQ

What was Hexima Ltd’s price range in the past 12 months?
Hexima Ltd lowest share price was AU$0.01 and its highest was AU$0.02 in the past 12 months.
    What is Hexima Ltd’s market cap?
    Currently, no data Available
    When is Hexima Ltd’s upcoming earnings report date?
    Hexima Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 113 days.
      How were Hexima Ltd’s earnings last quarter?
      Hexima Ltd released its earnings results on Feb 28, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
        Is Hexima Ltd overvalued?
        According to Wall Street analysts Hexima Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Hexima Ltd pay dividends?
          Hexima Ltd does not currently pay dividends.
          What is Hexima Ltd’s EPS estimate?
          Hexima Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Hexima Ltd have?
          Hexima Ltd has 167,039,630 shares outstanding.
            What happened to Hexima Ltd’s price movement after its last earnings report?
            Hexima Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Hexima Ltd?
              Currently, no hedge funds are holding shares in AU:HXL
              ---

              Hexima Ltd Stock Smart Score

              6
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              0.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              -26.54%
              Trailing 12-Months
              Asset Growth
              -38.37%
              Trailing 12-Months

              Company Description

              Hexima Ltd

              Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics. It is developing a product for the treatment of fungal nail infections.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Sonic Healthcare Limited
              Alcidion Group Limited
              Anatara Lifesciences Ltd
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis